| Literature DB >> 30190365 |
Alexander C Day1,2, Mukesh Dhariwal3, Michael S Keith3, Frank Ender4, Caridad Perez Vives4, Cristiana Miglio5, Lu Zou5, David F Anderson6,7.
Abstract
PURPOSE: To assess the prevalence and severity of preoperative and postoperative astigmatism in patients with cataract in the UK.Entities:
Keywords: angle; epidemiology; treatment other; vision
Mesh:
Year: 2018 PMID: 30190365 PMCID: PMC6591741 DOI: 10.1136/bjophthalmol-2018-312025
Source DB: PubMed Journal: Br J Ophthalmol ISSN: 0007-1161 Impact factor: 4.638
Figure 1Population selection and attrition for eyes included in the study population. IOL, intraocular lens; UDVA, uncorrected distance visual acuity.
Baseline characteristics for the 110 468 study eyes
| Variable | Category | N (% of total) |
| Age | Mean (SD): 78.84 (7.01) | 76 910 (100) |
| Sex | Female | 46 019 (60) |
| Male | 30 866 (40) | |
| Unknown/unspecified | 25 (0) | |
| Ethnicity | British | 25 505 (33) |
| Unknown/unspecified | 49 954 (65) | |
| Other | 1451 (2) | |
| Co-pathologies recorded on the date of cataract surgery | None | 70 094 (63) |
| At least 1 recorded* | 40 374 (36) | |
| Age-related macular degeneration | 10 841 (9) | |
| Amblyopia | 1260 (1) | |
| Brunescent/white cataract | 3792 (3) | |
| Corneal pathology | 2603 (2) | |
| Diabetic retinopathy | 4574 (4) | |
| Glaucoma | 10 215 (9) | |
| High myopia | 3247 (3) | |
| Inherited eye disease | 96 (0) | |
| No fundal view/vitreous opacities | 812 (1) | |
| Central nervous system disease | 372 (0) | |
| Other macular pathology | 933 (1) | |
| Other retinal vascular pathology | 161 (0) | |
| Previous laser refractive surgery | 3 (0) | |
| Pars plana vitrectomy | 691 (1) | |
| Previous retinal detachment surgery | 906 (1) | |
| Previous trabeculectomy | 469 (0) | |
| Pseudoexfoliation/phacodonesis | 1359 (1) | |
| Retinal vascular occlusion | 845 (1) | |
| Uveitis/synaechiae | 821 (1) | |
| Vitrectomy | 131 (0) | |
| Vitreous opacification | 636 (1) | |
| Other | 3760 (3) |
*Individual co-pathology frequency is reported as number and proportion of total eyes with at least one record of co-pathologies. Please note that one eye may have record of more than one co-pathology.
Corneal astigmatism cylinder for the 110 468 eyes, according to astigmatism type
| Astigmatism types | N (%) | Mean | SD | Median | IQR |
| All astigmatism | 1 10 468 | 1.06 | 0.81 | 0.85 | 0.52–1.35 |
| With-the-rule (WTR) | 33 878 (30.1%) | 1.08 | 0.83 | 0.87 | 0.54–1.35 |
| Against-the-rule (ATR) | 46 999 (42.5%) | 1.14 | 0.82 | 0.96 | 0.58–1.49 |
| Oblique | 18 826 (17.0%) | 0.8 | 0.64 | 0.64 | 0.41–0.99 |
| Unknown/missing | 10 765 (9.7%) | 1.07 | 0.84 | 0.86 | 0.51–1.37 |
Figure 2Distribution of preoperative (corneal) (solid line) and postoperative (refractive) astigmatism (dashed line). The preoperative population includes all eligible eyes (N=110 468), while the postoperative population contains all eyes with monofocal intraocular lens (IOLs) and an eligible refractive measurement (N=39 744).
Figure 3Distribution of preoperative (corneal) astigmatism according to type (A) and the distribution of postoperative (refractive) astigmatism according to co-pathology (B). The preoperative population includes all eligible eyes (N=1 10 468), while the postoperative population contains all eyes with monofocal intraocular lens (IOLs) and an eligible refractive cylinder value (N=39 744). Proportions reflect cases exceeding a certain level of preoperative and postoperative astigmatism.
Figure 4Power vectors for all eyes implanted with monofocal intraocular lens (IOL) with both refractive cylinder and steepest meridian recorded 2–12 months postsurgery and preoperative astigmatism ≥0.5 D (n=28 845) for (A) all eyes, (B) eyes with and without co-pathologies and (C) eyes operated with and off the steepest meridian. Each point indicates the mean vector value. The arrow indicates the direction of change between presurgery and postsurgery (and not the magnitude). The P values represent the result of Hotelling’s T2 test (A) and the multivariate linear regression adjusted for presence of co-pathologies (B) and steepest meridian of surgery (C).
Proportion of eyes with UDVA/BDVA ≤0.10 (logMAR)
| Statistics | All eyes with a valid record | Without co-pathologies | With co-pathologies | Without co-pathologies | With co-pathologies | ||
| With the steepest meridian | Off the steepest meridian | With the steepest meridian | Off the steepest meridian | ||||
| N with UDVA | 33 219 | 6583 | 15 438 | 3197 | 8001 | 22 021 | 11 198 |
| UDVA ≤0.10 (N, %) | 8600 (25.9) | 2251 (6.8) | 4122 (12.4) | 718 (2.2) | 1509 (4.5) | 6373 (19.2) | 2227 (6.7) |
| N with BDVA | 55 268 | 10 204 | 24 523 | 5697 | 14 844 | 34 727 | 20 541 |
| BDVA≤0.10 (N, %) | 28 204 (51.0) | 5986 (10.8) | 13 906 (25.2) | 2389 (4.3) | 5923 (10.7) | 19 892 (36.0) | 8312 (15.0) |
BDVA, best-measured distant visual acuity; UDVA, uncorrected distance visual acuity.
figure 5Box plot of UDVA (A) and BDVA (B) scores according to surgery axis and presence of co-pathologies. Note that eyes with preoperative corneal astigmatism <0.5 D were excluded.
figure 6Uncorrected distance visual acuity (UDVA) levels at different categories of astigmatism severity for eyes with refraction and UDVA measured after surgery (N=19 095). Mild astigmatism:<1.5 D, moderate: 1.5 -<2.5 D and severe: 2.5 -<5.5 D.3 Eyes with ≥5.5 D were considered as potentially pathological corneas.